Author:
Pfaller M. A.,Barry A. L.,Fuchs P. C.,Gerlach E. H.,Hardy D. J.,McLaughlin J. C.
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference12 articles.
1. Aronoff SC, Jacobs MR, Johenning S, Yamabe S Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin. Antimicrobial Agents and Chemotherapy 1984, 26: 580–582.
2. Jacobs MR, Aronoff SC, Johenning S, Shlaes DM, Yamabe S Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with ampicillin and broad spectrum penicillins against defined beta-lactamase-producing aerobic gram-negative bacilli. Antimicrobial Agents and Chemotherapy 1986, 29: 980–985.
3. Klastersky J, van der Auwera P In vitro activity of sulbactam in combination with various beta-lactam antibiotics. Diagnostic Microbiology and Infectious Disease 1989, 12, Supplement 4: 1655–1695.
4. English AR, Retsema JA, Girard AE, Lynch JE, Barth WE CP-45,899, a beta-lactamase inhibitor that extends the antibacterial spectrum of beta-lactams: initial bacteriological characterization. Antimicrobial Agents and Chemotherapy 1978, 14: 414–419.
5. Jones RN In vitro evaluations of aminopenicillin/β-lactamase inhibitor combinations. Drugs 1988, 35, Supplement 7: 17–26.
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献